Unknown

Dataset Information

0

Tumour extracellular vesicles and particles induce liver metabolic dysfunction.


ABSTRACT: Cancer alters the function of multiple organs beyond those targeted by metastasis1,2. Here we show that inflammation, fatty liver and dysregulated metabolism are hallmarks of systemically affected livers in mouse models and in patients with extrahepatic metastasis. We identified tumour-derived extracellular vesicles and particles (EVPs) as crucial mediators of cancer-induced hepatic reprogramming, which could be reversed by reducing tumour EVP secretion via depletion of Rab27a. All EVP subpopulations, exosomes and principally exomeres, could dysregulate hepatic function. The fatty acid cargo of tumour EVPs-particularly palmitic acid-induced secretion of tumour necrosis factor (TNF) by Kupffer cells, generating a pro-inflammatory microenvironment, suppressing fatty acid metabolism and oxidative phosphorylation, and promoting fatty liver formation. Notably, Kupffer cell ablation or TNF blockade markedly decreased tumour-induced fatty liver generation. Tumour implantation or pre-treatment with tumour EVPs diminished cytochrome P450 gene expression and attenuated drug metabolism in a TNF-dependent manner. We also observed fatty liver and decreased cytochrome P450 expression at diagnosis in tumour-free livers of patients with pancreatic cancer who later developed extrahepatic metastasis, highlighting the clinical relevance of our findings. Notably, tumour EVP education enhanced side effects of chemotherapy, including bone marrow suppression and cardiotoxicity, suggesting that metabolic reprogramming of the liver by tumour-derived EVPs may limit chemotherapy tolerance in patients with cancer. Our results reveal how tumour-derived EVPs dysregulate hepatic function and their targetable potential, alongside TNF inhibition, for preventing fatty liver formation and enhancing the efficacy of chemotherapy.

SUBMITTER: Wang G 

PROVIDER: S-EPMC10330936 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumour extracellular vesicles and particles induce liver metabolic dysfunction.

Wang Gang G   Li Jianlong J   Bojmar Linda L   Chen Haiyan H   Li Zhong Z   Tobias Gabriel C GC   Hu Mengying M   Homan Edwin A EA   Lucotti Serena S   Zhao Fengbo F   Posada Valentina V   Oxley Peter R PR   Cioffi Michele M   Kim Han Sang HS   Wang Huajuan H   Lauritzen Pernille P   Boudreau Nancy N   Shi Zhanjun Z   Burd Christin E CE   Zippin Jonathan H JH   Lo James C JC   Pitt Geoffrey S GS   Hernandez Jonathan J   Zambirinis Constantinos P CP   Hollingsworth Michael A MA   Grandgenett Paul M PM   Jain Maneesh M   Batra Surinder K SK   DiMaio Dominick J DJ   Grem Jean L JL   Klute Kelsey A KA   Trippett Tanya M TM   Egeblad Mikala M   Paul Doru D   Bromberg Jacqueline J   Kelsen David D   Rajasekhar Vinagolu K VK   Healey John H JH   Matei Irina R IR   Jarnagin William R WR   Schwartz Robert E RE   Zhang Haiying H   Lyden David D  

Nature 20230524 7964


Cancer alters the function of multiple organs beyond those targeted by metastasis<sup>1,2</sup>. Here we show that inflammation, fatty liver and dysregulated metabolism are hallmarks of systemically affected livers in mouse models and in patients with extrahepatic metastasis. We identified tumour-derived extracellular vesicles and particles (EVPs) as crucial mediators of cancer-induced hepatic reprogramming, which could be reversed by reducing tumour EVP secretion via depletion of Rab27a. All EV  ...[more]

Similar Datasets

| S-EPMC10415595 | biostudies-literature
2023-03-09 | GSE199863 | GEO
| S-EPMC10243901 | biostudies-literature
| S-EPMC11758215 | biostudies-literature
| S-EPMC7661699 | biostudies-literature
| S-EPMC8058445 | biostudies-literature
| S-EPMC7574205 | biostudies-literature
| S-EPMC8663554 | biostudies-literature
| S-EPMC5531255 | biostudies-literature